Russia tests coronavirus vaccine on 5 000 volunteers

RUSSIA / FSU POLITICS - In Brief 29 Sep 2020 by Alex Teddy
On September 28 Moscow announced that it was testing Sputnik V on 5 000 people including those who have an elevated risk of infection. This is the last stage of the trials.The Gamaleya Research Center said that the trials will eventually involve 40 000 volunteers. It is admitted that there are side effects such as fever and pain around the injection point. This is the norm for vaccines. Sputnik V is an adenovirus based vector vaccine. Trials will end in May 2021 all being well. The sovereign wealth fund is financing Sputnik V. On September 25 Sputnik V was delivered to Belarus. Coronavirus is spreading rapidly in Russia as the weather cools. Moscow schoolchildren will be given an unprecedented break October 5-18 to stem the tide of coronavirus.

Now read on...

Register to sample a report

Register
Sign-in
Forgot your password?
Copyright 2024 GlobalSource Partners. All rights reserved. This is prepared for GlobalSource Partners’ clients and may not be redistributed, reproduced, stored in a retrieval system, retransmitted or disclosed, in whole or in part, or in any form or manner, without the express written consent of GlobalSource Partners. This is distributed simultaneously to our website and other portals used by GlobalSource Partners. The information herein was obtained from various sources and is believed to be reliable but GlobalSource Partners does not warrant its completeness or accuracy. Neither GlobalSource Partners nor any Country Analyst, officer or employee accepts any liability whatsoever for any direct, indirect or consequential damages or losses rising from any use of this or its contents.